BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND APC, DP2, 324, ENSG00000134982, P25054, FPC, GS, DP3, DP2_5 AND Prognosis
121 results:

  • 1. The crucial role of age and site in incidence and prognosis of female neuroendocrine neoplasms in the United States: a population-based study from 2000 to 2018.
    Xiao G; Xu Z; Zhang Y; Dai S; Ouyang G; Huang Y; Liu Y; Cao D; Luo F
    Aging (Albany NY); 2024 Mar; 16(5):4204-4223. PubMed ID: 38431305
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Identification and validation of a glycolysis-related taxonomy for improving outcomes in glioma.
    Ying T; Lai Y; Lu S; E S
    CNS Neurosci Ther; 2024 Feb; 30(2):e14601. PubMed ID: 38332637
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular signature of stem-like glioma cells (SLGCs) from human glioblastoma and gliosarcoma.
    Zechel C; Loy M; Wegner C; Dahlke E; Soetje B; Baehr L; Leppert J; Ostermaier JJ; Lueg T; Nielsen J; Elßner J; Willeke V; Marzahl S; Tronnier V; Madany Mamlouk A
    PLoS One; 2024; 19(2):e0291368. PubMed ID: 38306361
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A novel molecular subtyping based on multi-omics analysis for prognosis predicting in colorectal melanoma: A 16-year prospective multicentric study.
    Liu C; Cheng X; Han K; Hong L; Hao S; Sun X; Xu J; Li B; Jin D; Tian W; Jin Y; Wang Y; Fang W; Bao X; Zhao P; Chen D
    Cancer Lett; 2024 Mar; 585():216663. PubMed ID: 38246221
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. APOBEC3C is a novel target for the immune treatment of lower-grade gliomas.
    Zhao S; Li Y; Xu J; Shen L
    Neurol Res; 2024 Mar; 46(3):227-242. PubMed ID: 38007705
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Comparative Analysis of the Prognostic Significance of IDH,TERT, EGFR and MGMT Status in Patients with Adult Non-H3-Altered Grade 4 Gliomas: A Prospective Cohort Study.
    Alimohamadi M; Larijani A; Pour-Rashidi A; Farzin M; Ebrahimi H; Rahmani M; Hendi K; Yarandi KK; Aghajanian S; Shirani M
    World Neurosurg; 2024 Jan; 181():e628-e639. PubMed ID: 37914076
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Telomere maintenance mechanism subtype reveals different immune activity in vestibular schwannoma.
    Sung JY; Lee JW
    J Neurooncol; 2023 Oct; 165(1):113-126. PubMed ID: 37864645
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Prognostic Differences Between Surveillance and Active Treatment After Initial Orchiectomy in Patients With Stage I Mixed germ cell tumors of the Testis: A Propensity Score Matching Analysis.
    Du Y; Liu L; Zou B; Chen Z; Chen Q; Deng R; Yang P
    J Surg Res; 2024 Feb; 294():26-36. PubMed ID: 37857140
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Genetic insights into thymic carcinomas and thymic neuroendocrine neoplasms denote prognosis signatures and pathways.
    Wang S; Gu Z; Zhu L; Han Y; Yu H; Fang W; Han B
    Chin Med J (Engl); 2023 Nov; 136(22):2712-2721. PubMed ID: 37749819
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Gastric schwannoma: A retrospective analysis of clinical characteristics, treatments, and outcomes.
    Li J; Chen JH; Huang WF; Liu M; Hong SK; Zhang JY
    Asian J Surg; 2024 Jan; 47(1):407-412. PubMed ID: 37741754
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Epidemiological trends for functional pancreatic neuroendocrine tumors: A study combining multiple imputation with age adjustment.
    Luo S; Wang J; Wu L; Wang C; Yang J; Li M; Zhang L; Ge J; Sun C; Li E; Lei J; Liao Y; Zhou F; Liao W
    Front Endocrinol (Lausanne); 2023; 14():1123642. PubMed ID: 37113484
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Different miRNAs Related to
    Kang HS; Park HY; Lim H; Son IT; Kim MJ; Kim NY; Kim MJ; Nam ES; Cho SJ; Kwon MJ
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047300
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. The characteristics of serum lipid spectrum in PanNENs and its correlation with clinicopathological features and prognosis.
    Meng YF; Fan ZY; Yang J; Li YZ; Liu SJ; Gao CH; Gao X; Pang CY; Zhan HX
    Front Endocrinol (Lausanne); 2023; 14():1137911. PubMed ID: 37033225
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Incidence and survival of patients with primary gastrointestinal melanoma: a population-based study.
    Du Y; Chang X; Li X; Xing S
    Int J Colorectal Dis; 2023 Mar; 38(1):87. PubMed ID: 36991139
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The other colon cancer: a population-based cohort study of appendix tumour trends and prognosis.
    Halfter K; Schubert-Fritschle G; Klauschen F; Werner J; Mayerle J; Weichert W; Friess H; Schmid R; Kremer M; Ruppert R; Hoelzl J; Krenz D; Nerlich A; Agha A; Fuchs M; Becker I; Nowak K; Engel J; Schlesinger-Raab A
    Colorectal Dis; 2023 May; 25(5):943-953. PubMed ID: 36748436
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma.
    Huang R; Shen G; Ren Y; Zheng K; Wang J; Shi Y; Yin JC; Qin L; Zhang G; Zhao M; Su X; Li L; Wang F; Shao Y; Liu B; Zou Z
    J Transl Med; 2023 Feb; 21(1):78. PubMed ID: 36739402
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Recurrence of gastric schwannoma.
    Ruiz Pardo J; Sánchez Fuentes PA; García Redondo M; Gras Gómez CM; Vidaña Márquez E; Belda Lozano R; Ferrer-Márquez M; Reina Duarte Á
    Rev Esp Enferm Dig; 2023 Apr; 115(4):215-216. PubMed ID: 36719332
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Coincidence of primary adrenocortical carcinoma and melanoma: three CASE reports.
    Ko YL; Kumar V; Lippert J; Diaz-Cano S; Skordilis K; Kimpel O; Kircher S; Asia M; Elhassan YS; Altieri B; Ronchi CL
    BMC Endocr Disord; 2023 Jan; 23(1):4. PubMed ID: 36604647
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Immunological profiles of human oligodendrogliomas define two distinct molecular subtypes.
    Wu F; Yin YY; Fan WH; Zhai Y; Yu MC; Wang D; Pan CQ; Zhao Z; Li GZ; Zhang W
    EBioMedicine; 2023 Jan; 87():104410. PubMed ID: 36525723
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy.
    Liang X; Wang Z; Dai Z; Zhang H; Zhang J; Luo P; Liu Z; Liu Z; Yang K; Cheng Q; Zhang M
    Cancer Gene Ther; 2023 Mar; 30(3):481-496. PubMed ID: 36494582
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 7.